$IRBT
IROBOT CORP Stock $irbt

$irbt Overview Financials Valuation SEC Filings Company Website

2013 Q1 Form 10-Q Financial Statement

#000115916713000014 Filed on May 03, 2013

Income Statement

Concept	2013 Q1	2012 Q1
Revenue	$106.2M	$97.81M
YoY Change	8.58%	-14.2%
Cost Of Revenue	$59.67M	$59.26M
YoY Change	0.7%	-13.5%
Gross Profit	$46.56M	$38.55M
YoY Change	20.77%	-15.27%
Gross Profit Margin	43.84%	39.42%
Selling, General & Admin	$23.16M	$23.38M
YoY Change	-0.94%	-20.76%
% of Gross Profit	49.73%	60.63%
Research & Development	$14.41M	$14.50M
YoY Change	-0.63%	72.62%
% of Gross Profit	30.95%	37.61%
Depreciation & Amortization	$3.284M	$2.602M
YoY Change	26.21%	44.56%
% of Gross Profit	7.05%	6.75%
Operating Expenses	$37.56M	$37.88M
YoY Change	-0.82%	-0.07%
Operating Profit	$8.964M	$677.0K
YoY Change	1224.08%	-91.09%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$96.00K	$220.0K
YoY Change	-143.64%	120.0%
Pretax Income	$8.868M	$897.0K
YoY Change	888.63%	-88.35%
Income Tax	$513.0K	$244.0K
% Of Pretax Income	5.78%	27.2%
Net Earnings	$8.355M	$653.0K
YoY Change	1179.48%	-90.67%
Net Earnings / Revenue	7.87%	0.67%
Basic Earnings Per Share	$0.30	$0.02
Diluted Earnings Per Share	$0.29	$0.02
COMMON SHARES
Basic Shares Outstanding	27.93M shares	27.35M shares
Diluted Shares Outstanding	28.56M shares	28.28M shares

Balance Sheet

Concept	2013 Q1	2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$137.4M	$182.1M
YoY Change	-24.55%	48.9%
Cash & Equivalents	$133.9M	$166.8M
Short-Term Investments	$13.90M	$15.30M
Other Short-Term Assets	$9.811M	$21.30M
YoY Change	-53.94%	11.52%
Inventory	$32.16M	$31.70M
Prepaid Expenses
Receivables	$27.28M	$31.10M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$228.3M	$266.2M
YoY Change	-14.24%	28.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$23.63M	$28.20M
YoY Change	-16.21%	10.16%
Goodwill	$48.95M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.50M	$29.10M
YoY Change	-63.91%	55.61%
Total Long-Term Assets	$119.0M	$59.60M
YoY Change	99.6%	24.95%
TOTAL ASSETS
Total Short-Term Assets	$228.3M	$266.2M
Total Long-Term Assets	$119.0M	$59.60M
Total Assets	$347.3M	$325.8M
YoY Change	6.58%	28.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$29.80M	$44.30M
YoY Change	-32.72%	14.47%
Accrued Expenses	$13.98M	$26.80M
YoY Change	-47.85%	-20.24%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$54.41M	$73.60M
YoY Change	-26.08%	-2.9%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$5.000M	$4.200M
YoY Change	19.05%	16.67%
Total Long-Term Liabilities	$5.033M	$4.200M
YoY Change	19.83%	16.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$54.41M	$73.60M
Total Long-Term Liabilities	$5.033M	$4.200M
Total Liabilities	$59.44M	$77.80M
YoY Change	-23.6%	-2.02%
SHAREHOLDERS EQUITY
Retained Earnings	$83.79M
YoY Change
Common Stock	$203.8M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$287.8M	$248.1M
YoY Change
Total Liabilities & Shareholders Equity	$347.3M	$325.8M
YoY Change	6.58%	28.12%

Cashflow Statement

Concept	2013 Q1	2012 Q1
OPERATING ACTIVITIES
Net Income	$8.355M	$653.0K
YoY Change	1179.48%	-90.67%
Depreciation, Depletion And Amortization	$3.284M	$2.602M
YoY Change	26.21%	44.56%
Cash From Operating Activities	$156.0K	$3.832M
YoY Change	-95.93%	-73.2%
INVESTING ACTIVITIES
Capital Expenditures	$1.077M	$1.643M
YoY Change	-34.45%	-132.22%
Acquisitions
YoY Change
Other Investing Activities	$2.000M	-$3.500M
YoY Change	-157.14%	-240.0%
Cash From Investing Activities	-$4.624M	-$5.143M
YoY Change	-10.09%	97.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.274M	$1.801M
YoY Change	-29.26%	-69.98%
NET CHANGE
Cash From Operating Activities	$156.0K	$3.832M
Cash From Investing Activities	-$4.624M	-$5.143M
Cash From Financing Activities	$1.274M	$1.801M
Net Change In Cash	-$3.194M	$490.0K
YoY Change	-751.84%	-97.23%
FREE CASH FLOW
Cash From Operating Activities	$156.0K	$3.832M
Capital Expenditures	$1.077M	$1.643M
Free Cash Flow	-$921.0K	$2.189M
YoY Change	-142.07%	-88.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	42515000	USD
CY2013Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	29804000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29413000	USD
CY2013Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27280000	USD
CY2013Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13977000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13642000	USD
CY2013Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	290000	USD
CY2012Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	155000	USD
CY2013Q1	us-gaap	Accrued Rent Current AccruedRentCurrent	739000	USD
CY2012Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	696000	USD
CY2012Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	475000	USD
CY2013Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	481000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	199000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	211000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	199903000	USD
CY2013Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	203528000	USD
CY2013Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	111000	USD
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	111000	USD
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1100000	shares
CY2012Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	500000	shares
CY2013Q1	us-gaap	Assets Assets	347251000	USD
CY2012Q4	us-gaap	Assets Assets	354313000	USD
CY2012Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	705000	USD
CY2012Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	705000	USD
CY2013Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	43000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	234893000	USD
CY2013Q1	us-gaap	Assets Current AssetsCurrent	228288000	USD
CY2012Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	12430000	USD
CY2012Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	60000	USD
CY2013Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	59000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	354313000	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	347251000	USD
CY2013Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	13869000	USD
CY2013Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	8355000	USD
CY2012Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-1254000	USD
CY2012Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	99943000	USD
CY2013Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	106195000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	126770000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	123576000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	166308000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	166798000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3194000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	490000	USD
CY2013Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28002847	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27781659	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27781659	shares
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28002847	shares
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	280000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	278000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8367000	USD
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	798000	USD
CY2012Q1	us-gaap	Contract Revenue Cost ContractRevenueCost	3022000	USD
CY2013Q1	us-gaap	Contract Revenue Cost ContractRevenueCost	1853000	USD
CY2013Q1	us-gaap	Contracts Revenue ContractsRevenue	4790000	USD
CY2012Q1	us-gaap	Contracts Revenue ContractsRevenue	6065000	USD
CY2012Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	59255000	USD
CY2013Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	59668000	USD
CY2013Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	57815000	USD
CY2012Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	56233000	USD
CY2013Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-449000	USD
CY2012Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6694000	USD
CY2013Q1	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	19340000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	19266000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	8792000	USD
CY2013Q1	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	8623000	USD
CY2012Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2602000	USD
CY2013Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3284000	USD
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.30
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2013Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.058
CY2012Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.272
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	11864000	USD
CY2013Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6997000	USD
CY2013Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	43000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4241000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3276000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	8997000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2895000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	3827000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3827000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3852000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3861000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	31500000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	31500000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	28224000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27259000	USD
CY2013Q1	us-gaap	Fiscal Period FiscalPeriod	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Year-End</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company operates and reports using a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">52</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">-53</font><font style="font-family:inherit;font-size:10pt;"> week fiscal year ending on the Saturday closest to December 31. Accordingly, the Company’s fiscal quarters end on the Saturday that falls closest to the last day of the third month of each quarter.</font></div></div>
CY2012Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-69000	USD
CY2013Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-182000	USD
CY2012Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11042000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12458000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	48951000	USD
CY2013Q1	us-gaap	Goodwill Goodwill	48951000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	46527000	USD
CY2012Q1	us-gaap	Gross Profit GrossProfit	38552000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	8868000	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	897000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	513000	USD
CY2012Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	244000	USD
CY2012Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	262000	USD
CY2013Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	1510000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-12711000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4104000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2133000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-13431000	USD
CY2012Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	895000	USD
CY2013Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2628000	USD
CY2012Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-10149000	USD
CY2013Q1	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1800000	USD
CY2013Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-4867000	USD
CY2012Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	592000	USD
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4805000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	2003000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	379000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	983000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2832000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	815000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-66000	USD
CY2012Q1	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-1122000	USD
CY2013Q1	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	1056000	USD
CY2012Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	28056000	USD
CY2013Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	26611000	USD
CY2013Q1	us-gaap	Inventory Net InventoryNet	32160000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	36965000	USD
CY2013Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	5490000	USD
CY2012Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	8849000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4541000	USD
CY2013Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5478000	USD
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	54407000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	74278000	USD
CY2012Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4218000	USD
CY2013Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5033000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1801000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1274000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4624000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5143000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3832000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	156000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	8355000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	653000	USD
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-96000	USD
CY2012Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	220000	USD
CY2013Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	Segment
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	37563000	USD
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	37875000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	8964000	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	677000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	18945000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	2353000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2505000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2747000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2820000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2837000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	5683000	USD
CY2012Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1100000	USD
CY2013Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1000000	USD
CY2013Q1	us-gaap	Other Assets Current OtherAssetsCurrent	9811000	USD
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8853000	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	2500000	USD
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8500000	USD
CY2013Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10501000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	145000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	12000	USD
CY2012Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	22000	USD
CY2013Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	11000	USD
CY2013Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	2547000	USD
CY2012Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1077000	USD
CY2012Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1643000	USD
CY2013Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	1000000	USD
CY2013Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1744000	USD
CY2012Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1323000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24953000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23629000	USD
CY2012Q4	us-gaap	Receivables Long Term Contracts Or Programs ReceivablesLongTermContractsOrPrograms	1196000	USD
CY2013Q1	us-gaap	Receivables Long Term Contracts Or Programs ReceivablesLongTermContractsOrPrograms	2252000	USD
CY2012Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14500000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14408000	USD
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	83792000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	75437000	USD
CY2013Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	583000	USD
CY2012Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	719000	USD
CY2012Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	91742000	USD
CY2013Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	101405000	USD
CY2012Q1	us-gaap	Sales Revenue Net SalesRevenueNet	97807000	USD
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	106195000	USD
CY2013Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	628000	shares
CY2012Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	931000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28558000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28283000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27352000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27930000	shares
CY2013Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10697000	USD
CY2012Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	12333000	USD
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2513000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2929000	USD
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	30000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	60000	shares
CY2012Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	22.86
CY2013Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	6021000	USD
CY2012Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	10132000	USD
CY2012Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	6057000	USD
CY2011Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	10306000	USD
CY2012Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	6057000	USD
CY2013Q1	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	6021000	USD
CY2012Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1088000	USD
CY2013Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	440000	USD
CY2013Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	404000	USD
CY2012Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	914000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	275817000	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	287811000	USD
CY2013Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of these financial statements in conformity with accounting principles generally accepted in the United States requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities. On an ongoing basis, management evaluates these estimates and judgments, including those related to revenue recognition, sales returns, bad debts, warranty claims, inventory reserves, valuation of investments, assumptions used in valuing stock-based compensation instruments and income taxes. The Company bases these estimates on historical and anticipated results and trends and on various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. By their nature, estimates are subject to an inherent degree of uncertainty. Actual results may differ from the Company’s estimates.</font></div></div>
CY2013Q1	irbt	Accrued Direct Fulfillment Costs AccruedDirectFulfillmentCosts	385000	USD
CY2012Q4	irbt	Accrued Direct Fulfillment Costs AccruedDirectFulfillmentCosts	999000	USD
CY2012Q4	irbt	Deferred Revenue And Customer Advances DeferredRevenueAndCustomerAdvances	6257000	USD
CY2013Q1	irbt	Deferred Revenue And Customer Advances DeferredRevenueAndCustomerAdvances	3629000	USD
CY2005Q4	irbt	Effective Date For Stock Options Plan EffectiveDateForStockOptionsPlan	2005-10-10
CY2012Q1	irbt	Income Tax Withholding Payment Associated With Restricted Stock Vesting IncomeTaxWithholdingPaymentAssociatedWithRestrictedStockVesting	227000	USD
CY2013Q1	irbt	Income Tax Withholding Payment Associated With Restricted Stock Vesting IncomeTaxWithholdingPaymentAssociatedWithRestrictedStockVesting	513000	USD
CY2013Q1	irbt	Increase Decrease In Other Assets IncreaseDecreaseInOtherAssets	2000000	USD
CY2012Q1	irbt	Increase Decrease In Other Assets IncreaseDecreaseInOtherAssets	6000000	USD
CY2013Q1	irbt	Increase In Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized IncreaseInShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	0.045
CY2013Q1	irbt	Number Of Customer Generating Major Revenues NumberOfCustomerGeneratingMajorRevenues	2	customer
CY2013Q1	dei	Amendment Flag AmendmentFlag	false
CY2013Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-28
CY2013Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2013Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013Q1	dei	Document Period End Date DocumentPeriodEndDate	2013-03-30
CY2013Q1	dei	Document Type DocumentType	10-Q
CY2013Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001159167
CY2013Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	28262221	shares
CY2013Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2013Q1	dei	Entity Registrant Name EntityRegistrantName	IROBOT CORP
CY2013Q1	dei	Trading Symbol TradingSymbol	IRBT

Files In Submission

Name	View Source	Status
0001159167-13-000014-index-headers.html	Edgar Link	pending
0001159167-13-000014-index.html	Edgar Link	pending
0001159167-13-000014.txt	Edgar Link	pending
0001159167-13-000014-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
irbt-20130329.xml	Edgar Link	completed
irbt-20130329.xsd	Edgar Link	pending
irbt-20130329_cal.xml	Edgar Link	unprocessable
irbt-20130329_def.xml	Edgar Link	unprocessable
irbt-20130329_lab.xml	Edgar Link	unprocessable
irbt-20130329_pre.xml	Edgar Link	unprocessable
irbt-2013330x10q.htm	Edgar Link	pending
irbtexhibit311.htm	Edgar Link	pending
irbtexhibit312.htm	Edgar Link	pending
irbtexhibit321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IRBT
IROBOT CORP Stock $irbt

2013 Q1 Form 10-Q Financial Statement

#000115916713000014 Filed on May 03, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRBT IROBOT CORP Stock $irbt

2013 Q1 Form 10-Q Financial Statement

#000115916713000014 Filed on May 03, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRBT
IROBOT CORP Stock $irbt